117th Congress · HOUSE BILLBILL

H.R. 9679Medical Cannabis Research Act of 2022

To increase the number of manufacturers registered under the Controlled Substances Act to manufacture cannabis for legitimate research purposes, to authorize health care providers of the Department of Veterans Affairs to provide recommendations to veterans regarding participation in federally approved cannabis clinical trials, and for other purposes.

Crime and law enforcement
Introduced Dec 22, 2022
Last action Dec 22, 2022
Pipeline · Bill → Law
Step 1
Introduced
Dec 22, 2022
Step 2
Referred
Dec 22, 2022
E&C · Judiciary · Veterans' Affairs
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 3 sectionsIntroduced in House
Timeline · 4 actions
Dec 22, 2022
Introduced in House
Dec 22, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 22, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 22, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.